Loading insider details...
Beta
Latest Form 4 (Sep 17, 2026): Exercise/Conversion of 1,300 ANAB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 17, 2026 | ANAPTYSBIO, INC (ANAB) | Exercise/Conversion | 1,300 | n/a |
| Sep 17, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Exercise/Conversion | 1,300 | n/a |
| Jun 17, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Exercise/Conversion | 6,030 | n/a |
| Jun 17, 2026 | ANAPTYSBIO, INC (ANAB) | Exercise/Conversion | 6,030 | n/a |
| May 21, 2026 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 4,000 | n/a |
| May 14, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/Award | 15,000 | n/a |
| Apr 22, 2026 | ANAPTYSBIO, INC (ANAB) | Disposition to Issuer | 3,311 | n/a |
| Apr 22, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/Award | 3,311 | n/a |
| Jan 8, 2026 | ANAPTYSBIO, INC (ANAB) | Grant/Award | 8,250 | n/a |
| Sep 17, 2025 | ANAPTYSBIO, INC (ANAB) | Exercise/Conversion | 1,300 | n/a |